A Rare Case of Concurrent Glomerulopathies: Atypical Anti-GBM Disease and Phospholipase A2 Receptor (PLA2R) Antibody-Negative Membranous Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB167; "Management includes carvedilol for blood pressure, sodium bicarbonate for metabolic acidosis, and pRBC transfusion for anemia. Retacrit was deferred pending hematologic workup for IgA lambda monoclonal gammopathy. Plasma cell-directed therapy was withheld as bone marrow findings were not diagnostic, and rituximab was considered for high-risk MN pending exclusion of secondary causes...Renal biopsy and serological tests should be used in combination to diagnose MN with anti-GBM. Figure 1: MPGN Pattern of Injury"
Clinical • Amyloidosis • Glioblastoma • Glomerulonephritis • Hematological Disorders • Hematological Malignancies • Metabolic Disorders • Monoclonal Gammopathy • Multiple Myeloma • Nephrology • Renal Disease
|
|
Ariv Tandon; Sofia Krivitsky; Anaya Sayal; Surabhi S. Chinta; Kiera Sheth; Anjay Rastogi
|